Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun Jin, Park, Seok O, Ko, Seung-Hyun, Rhee, Sang Youl, Hur, Kyu-Yeon, Kim, Nan-Hee, Moon, Min Kyong, Lee, Byung-Wan, Kim, Jin Hwa, Choi, Kyung Mook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741550/
https://www.ncbi.nlm.nih.gov/pubmed/29272081
http://dx.doi.org/10.4093/dmj.2017.41.6.423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741550/
https://www.ncbi.nlm.nih.gov/pubmed/29272081
http://dx.doi.org/10.4093/dmj.2017.41.6.423

Ejemplares similares